Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin [Phase 1]
GlaxoSmithKline completed a Phase 1 bioequivalence study of SECOTEX (tamsulosin hydrochloride) in Brazil, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin [Phase 1]
Phase 1 bioequivalence study of SECOTEX (tamsulosin hydrochloride) in Brazil for prostatic hyperplasia completed; results posted.
-
CLINICAL_TRIALS research · 2011-03-16Clinical Trial Update: 3D Recording of a Trans-rectal Prostate Biopsy [NA]
A clinical trial update describing 3D recording of a trans-rectal prostate biopsy; conditions listed include prostate cancer and benign pros…
-
FDA approval · 2011-03-01FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for finasteride submitted by Dr. Reddy's Laboratories Limited (an ANDA supplement/approval).
-
FDA approval · 2011-03-01FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
The FDA approved Accord Healthcare, Inc.'s supplemental application for finasteride, authorizing a generic version to be marketed. The produ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) [Phase 3]
Phase 3 clinical trial updates for cetrorelix pamoate given intramuscularly in men with symptomatic benign prostatic hyperplasia, with resul…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) [Phase 3]
This Phase 3 trial of cetrorelix pamoate for symptomatic benign prostatic hyperplasia has completed, with results posted.
-
FDA approval · 2010-12-22FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for finasteride from Camber Pharmaceuticals, authorizing the marketing of a generic finasteride prod…
-
FDA approval · 2010-12-21FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for finasteride from Teva Pharmaceuticals USA, Inc. This action approves changes to the product's la…
-
FDA approval · 2010-12-15FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a Supplemental Application for UROXATRAL (alfuzosin HCl) submitted by Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
A completed clinical trial update assessing whether alpha-blocker therapy influences changes in prostate-specific antigen (PSA) in men with …
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. [Phase 2]
This document reports the completion and posting of results for a Phase 2 exploratory trial of degarelix in benign prostatic hyperplasia.
-
CLINICAL_TRIALS research · 2010-11-23Clinical Trial Update: Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms [Phase 2]
Phase 2 study assessing urodynamic effects of UK-369,003 in men with lower urinary tract symptoms due to benign prostatic hyperplasia; the t…
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily [Phase 3]
Phase 3 trial results for daily tadalafil in patients with signs and symptoms of benign prostatic hyperplasia were posted after the study co…
-
FDA approval · 2010-10-04FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROSCAR (finasteride) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers [Phase 3]
A Phase 3 trial assessing tadalafil for relief of Benign Prostatic Hyperplasia symptoms in men already treated with alpha blockers; results …
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia [Phase 2]
Phase 2 extension study of GI198745 for benign prostatic hyperplasia has completed.
-
FDA approval · 2010-09-09FDA Approved: AVODART — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Avodart (dutasteride) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: ALF-ONE : ALFuzosin ONcE Daily [Phase 4]
Phase 4 trial of Alfuzosin taken once daily for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia [NA]
Clinical trial update for the chronic use of doxazosin in men with benign prostatic hyperplasia; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension [Phase 2]
A Phase 2 study evaluating once-daily tadalafil for 12 weeks in Japanese men with benign prostatic hyperplasia, followed by an open-label ex…
-
FDA approval · 2010-07-16FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for finasteride from Accord Healthcare, Inc., resulting in regulatory approval of a generic finaster…
-
FDA approval · 2010-07-15FDA Approved: TAMSULOSIN HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic version of tamsulosin hydrochloride (Sun Pharmaceutical Industries) through an original ANDA. The product is used to …
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients [NA]
A clinical trial update evaluating the effectiveness of Saw Palmetto and Sanmiaoshan for benign prostatic hyperplasia in Chinese patients; t…
-
FDA approval · 2010-06-15FDA Approved: DOXAZOSIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for doxazosin mesylate filed by Teva Pharmaceuticals USA, Inc. under ANDA075536.